Skip to content

Improvement and Standardization of Standards of Domestic Nerve Stimulation Devices for Treatment of Urinary and Fecal Incontinence in Elderly

Improvement and Standardization of Standards of Domestic Nerve Stimulation Devices for Treatment of Urinary and Fecal Incontinence in Elderly

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122960
Enrollment
Unknown
Registered
2026-04-20
Start date
2024-01-10
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder

Interventions

Non-invasive Tibial Nerve Stimulation Group:None
Pelvic floor rehabilitation therapy device group:None
Six-electrode sacral nerve stimulation group:None

Sponsors

Beijing Bo'ai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Be able to communicate well with researchers and be willing to comply with all the requirements of the trial. 2. Diagnosis of overactive bladder or voiding difficulty; 3. Consent to receive treatment with the following devices: Wearable Percutaneous :Tibial Nerve Stimulator or Pelvic Floor Rehabilitation Therapy Device or Six-Electrode Sacral Nerve Stimulator; 4. For patients with an inadequate response to, or unwillingness to take, oral medication.

Exclusion criteria

Exclusion criteria: 1. Patients who have had a cardiac pacemaker or implantable defibrillator installed (impact of electrical stimulation on the safety of the pacemaker); 2. Those with uncontrolled symptomatic urinary tract infections, bladder tumors, and urinary tract stones are included. 3. Patients with epilepsy, senile dementia, brain atrophy, acute stage of cerebrovascular diseases, cognitive impairment, Parkinson's disease, and patients with complete spinal cord injury; 4. Mental disorders cannot be treated by doctors alone; 5. There are accompanying diseases that seriously affect health, such as malignant tumors; 6. Patients with grade II or above pelvic organ prolapse; 7. Patients who require indwelling urinary catheterization or intermittent catheterization to empty their bladders; 8. Other researchers believe that certain situations are not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Overactive Bladder Symptom Score;Urination efficiency;Frequency of urination;residual urine;

Secondary

MeasureTime frame
Patient Perception of Bladder Condition;American Urological Association Symptom Index Quality of Life;Wexner Constipation Scoring ;Cleveland Clinic Fecal Incontinence Score (CCFIS);

Countries

China

Contacts

Public ContactLi Xing

Beijing Bo'ai Hospital

lxcpums@126.com+86 10 87569040

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 30, 2026